322. Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension.
作者: Yogesh N V Reddy.;Robert P Frantz.;Paul M Hassoun.;Anna Hemnes.;Evelyn Horn.;Jane A Leopold.;Franz Rischard.;Erika B Rosenzweig.;Nicholas S Hill.;Serpil C Erzurum.;Gerald J Beck.;J Emanuel Finet.;Christine L Jellis.;Stephen C Mathai.;Reena Mehra.;W H Wilson Tang.;Barry A Borlaug.; .
来源: Circ Heart Fail. 2025年18卷8期e012912页
Patients with lung disease, sleep apnea, and chronic thromboemboli can develop pulmonary hypertension, currently classified as group 3 or 4. Many of these patients also have risk factors for heart failure with preserved ejection fraction (HFpEF), but the optimal approach to identify the disease overlap remains unclear.
323. Procedural and Clinical Outcomes According to Ultrasound-Guided Access in TAVI: A Propensity-Matched Comparative Subanalysis From the PULSE Registry.
作者: David Grundmann.;Tanja Rudolph.;Matti Adam.;Caroline Kellner.;Sabine Bleiziffer.;Daniel Braun.;Alexander R Tamm.;Max Meertens.;Matthias Renker.;Jonas Gmeiner.;Alexander Sedaghat.;David Leistner.;Christian W Hamm.;Hendrik Wienemann.;Norvydas Zapustas.;Benjamin Juri.;Mostafa Salem.;Roman Benetti-Lehmann.;Henryk Dreger.;Alina Gossling.;Awesta Nahif.;Stefan Blankenberg.;Hermann Reichenspurner.;Niklas Schofer.;Andreas Schaefer.;Jasmin Popara.;Misumasa Sudo.;Martin Geyer.;Marc Vorpahl.;Derk Frank.;Max Potratz.;Won Kim.;Moritz Seiffert.
来源: Circ Cardiovasc Interv. 2025年18卷8期e014771页
Access-related vascular and bleeding complications during transcatheter aortic valve implantation (TAVI) are associated with significant morbidity and mortality. Ultrasound-guided (USG) puncture may reduce the incidence of these adverse events, particularly in large-bore arterial access. However, large-scale data on this approach are limited, and it has not yet been fully implemented into standard clinical practice. We compared access-related vascular and bleeding complications in USG versus fluoroscopy-guided access from a large multicenter TAVI registry.
324. Long-Term Risk Assessment in Athletes With Complex Ventricular Arrhythmias.
作者: Paolo Compagnucci.;Michela Casella.;Maria Lucia Narducci.;Edoardo Conte.;Michela Cammarano.;Gemma Pelargonio.;Daniele Andreini.;Vincenzo Palmieri.;Giulia Stronati.;Gerardo V Lo Russo.;Matteo Brusamolino.;Gianluca Pontone.;Federico Guerra.;Andrea Natale.;Claudio Tondo.;Filippo Crea.;Paolo Zeppilli.;Antonio Dello Russo.
来源: Circ Arrhythm Electrophysiol. 2025年18卷6期e013480页
Ventricular arrhythmias (VAs) are a major concern in athletes. We sought to determine the prognostic role of noninvasive and invasive assessments in athletes with complex VAs.
325. Association of Pathogenic/Likely Pathogenic Genetic Variants for Cardiomyopathies With Clinical Outcomes: A Multiancestry Analysis in the All of Us Research Program.
作者: Naman S Shetty.;Akhil Pampana.;Mokshad Gaonkar.;Nirav Patel.;Nehal Vekariya.;J Gustav Smith.;Rajat Kalra.;C Anwar A Chahal.;Christopher Semsarian.;Peng Li.;Garima Arora.;Pankaj Arora.
来源: Circ Genom Precis Med. 2025年18卷3期e005113页
This study aimed to evaluate the prevalence of pathogenic/likely pathogenic cardiomyopathy variant carriers in a multiancestry US population and examine the risk of adverse clinical outcomes.
330. Response by Kristensen et al to Letter Regarding Article, "Half-Life and Clearance of Cardiac Troponin I and Troponin T in Humans".
作者: Jonas Henrik Kristensen.;Rasmus Bo Hasselbalch.;Nina Strandkjær.;Peter Hasse Møller-Sørensen.;Pia Rørbæk Kamstrup.;Morten Dahl.;Mustafa Vakur Bor.;Ruth Frikke-Schmidt.;Niklas Rye Jørgensen.;Line Rode.;Lene Holmvang.;Jesper Kjærgaard.;Lia Evi Bang.;Julie Forman.;Kim Dalhoff.;Allan S Jaffe.;Kristian Thygesen.;Henning Bundgaard.;Kasper Karmark Iversen.
来源: Circulation. 2025年151卷21期e1028-e1029页 331. Blood Pressure Lowering Effects of a Novel Long-Acting NPR1 Agonist, XXB750, in Healthy Participants: A Randomized, First-in-Human Clinical Study.
作者: YanLing He.;Xueping Wu.;Andre Serra-Roma.;Maggie Markiewicz.;Emma Healy.;Jing-He Yan.;Kenneth Kulmatycki.;Tong Zhang.;John L Diener.;Arvind G Kinhikar.;Denise P Yates.;David Nguyen.;Markus Hinder.;Cesare Russo.;Christopher J O'Donnell.
来源: Circulation. 2025年151卷21期1544-1546页 332. Ethical Considerations for Informed Consent in Acute Myocardial Infarction Clinical Trials.
作者: Manasi Tannu.;W Schuyler Jones.;John H Alexander.;Roxana Mehran.;Adrian F Hernandez.;Jennifer A Rymer.
来源: Circ Cardiovasc Interv. 2025年18卷7期e015016页
Obtaining informed consent for clinical trial participation in acute myocardial infarction presents unique ethical and logistical challenges because of the patient distress, sedation, and the urgency of treatment. Traditional consent procedures often conflict with the narrow enrollment windows, prompting the use of legally authorized representatives and short- and long-form consent models. Although these approaches enable faster trial enrollment, they may compromise patient autonomy, introduce selection bias, or create postenrollment ethical dilemmas. This review explores the complexities of informed consent in acute myocardial infarction research, evaluating the advantages and limitations of existing strategies, including legally authorized representative consent, 2-step consent processes, and alternatives such as deferred and verbal consent. It also examines international variations in regulatory oversight and presents emerging solutions, such as preemptive consent, opt-out models, electronic platforms, and registry-based trials, to streamline the enrollment without delaying care. Ultimately, consent regulations should be re-evaluated and potentially relaxed to better support timely research. A thoughtful reassessment of consent frameworks is essential to ethically and effectively advance acute myocardial infarction research in time-sensitive settings.
333. Impact of Coronary Artery Disease on Cardiovascular Outcomes Differs Between Men and Women With Severe Aortic Stenosis.
作者: Kayla Brown.;Ke Xu.;Rebecca T Hahn.;Philippe Pibarot.;Jonathon A Leipsic.;Ying Ma.;Marie-Annick Clavel.;Sammy Elmariah.;Neil J Weissman.;Federico M Asch.;Omar K Khalique.;Martin B Leon.;Paul C Cremer.;Brian R Lindman.;Maria C Alu.;Pamela S Douglas.;Melissa A Daubert.
来源: Circ Cardiovasc Interv. 2025年18卷8期e014999页
There is heterogeneity in coronary artery disease (CAD) severity among individuals with severe aortic stenosis (AS), but whether this differentially influences prognosis is unknown.
334. Mechanisms Underlying Sinus Node Dysfunction in a Rat Model of Genetic Atrial Cardiomyopathy.
作者: Edouard Marcoux.;Martin Mackasey.;Deanna Sosnowski.;Patrice Naud.;Louis R Villeneuve.;Martin G Sirois.;Jean-Claude Tardif.;T Alexander Quinn.;Stanley Nattel.
来源: Circ Arrhythm Electrophysiol. 2025年18卷6期e013180页
Sinoatrial node (SAN) dysfunction is commonly associated with atrial dysrhythmia (tachy-brady syndrome) and is a particularly important feature of inherited atrial cardiomyopathies leading to artificial pacemaker implantation. Essential MYL4 (myosin light chain-4) is an atrial-selective protein that associates with the myosin light chain and participates importantly in cardiacmuscle contraction. MYL4 gene variants encoding dysfunctional versions of MYL4 cause familial atrial cardiomyopathy with a high incidence of early SAN dysfunction (SND) and pacemaker requirement. In this study, we used a rat line, genetically modified to express an E11K gene mutation responsible for familial atrial cardiomyopathy, to address the mechanisms underlying SND.
335. Disruption of cTnT-Mediated Sarcomere-Mitochondrial Communication Results in Dilated Cardiomyopathy.
作者: Lingqun Ye.;Junwei Liu.;Wei Lei.;Baoqiang Ni.;Xinglong Han.;Yan Zhang.;Yong Wang.;Kaili Hao.;Yuanhui Peng.;Hongchun Wu.;Miao Yu.;Huadong Li.;Zhen-Ao Zhao.;Zhenya Shen.;Jianyi Zhang.;Shijun Hu.
来源: Circulation. 2025年152卷6期397-415页
Dilated cardiomyopathy (DCM) is substantially influenced by genetic factors. Sarcomere function is intricately associated with other organelles, particularly the reciprocal regulation between sarcomeres and mitochondria. Mitochondrial stress dysregulation is linked to DCM progression, yet mechanisms remain unclear. In this study, we investigated the effects of cTnT (cardiac troponin T) dysregulation on sarcomere-mitochondrial communication in DCM.
336. Development and Validation of Polygenic Risk Scores for Blood Pressure Traits in Continental African Populations.
作者: Ebuka Onyenobi.;Michael Zhong.;Opeyemi Soremekun.;Abram Kamiza.;Romuald Boua.;Tinashe Chikowore.; .;Segun Fatumo.;Ananyo Choudhury.;Scott Hazelhurst.;Clement Adebamowo.;Michèle Ramsay.;Bamidele Tayo.;Jennifer S Albrecht.;Timothy D O'Connor.;Yuji Zhang.;Braxton D Mitchell.;Sally N Adebamowo.
来源: Circ Genom Precis Med. 2025年18卷3期e005048页
Most polygenic risk scores (PRS) have been developed in European populations, frequently leading to limited transferability across diverse ancestry populations. This study aimed to develop and evaluate PRS for blood pressure (BP) traits in continental African populations and investigate how African genetic diversity influences PRS performance.
337. Identification and Functional Assessment of Candidate Causal Cis-Regulatory Variants Underlying Electrocardiographic QT Interval GWAS Loci.
作者: Supraja Kadagandla.;Lavanya Gunamalai.;Dongwon Lee.;Ashish Kapoor.
来源: Circ Genom Precis Med. 2025年18卷3期e005032页
Identifying causal variants among tens or hundreds of associated variants at each locus in genome-wide association studies is challenging. As the vast majority of genome-wide association studies variants are noncoding, sequence variation at cis-regulatory elements (CREs) affecting transcriptional expression of specific genes is a widely accepted molecular hypothesis. Following this hypothesis, combined with the observation that open chromatin is a universal hallmark of all types of CREs, we aimed to identify candidate causal cis-regulatory variants underlying QT interval genome-wide association studies loci.
338. Genotype-Specific Outcomes of Desmosomal Cardiomyopathies.
作者: Valerio Pergola.;Alessandro Trancuccio.;Deni Kukavica.;Andrea Mazzanti.;Carlo Napolitano.;Gabriele Gaetano Scilabra.;Kenneth Steele.;Mirella Memmi.;Patrick Gambelli.;Andrea Sugamiele.;Alessia Chiara Latini.;Nicola Pisani.;Giulio Mazzotta.;Raffaella Bloise.;Massimo Morini.;Maira Marino.;Silvia G Priori.
来源: Circulation. 2025年152卷4期233-245页
Desmosomal gene variants (DGVs) have been associated with a diverse spectrum of phenotypic manifestations within arrhythmogenic cardiomyopathy, but data on genotype-specific outcomes are lacking. We investigated genotype-specific arrhythmic and heart failure (HF) outcomes in DGV carriers.
339. Shorter Time to Transcatheter Aortic Valve Implantation Is Associated With Improved Outcomes in Acute Decompensated Aortic Stenosis.
作者: Michael McKenna.;Niromila Nadarajan.;Sumanto Mukhopadhyay.;Mick Ozkor.;Thomas A Treibel.;Guy Lloyd.;Sanjeev Bhattacharyya.;Anthony Mathur.;Simon Kennon.;Andreas Baumbach.;Michael J Mullen.;Kush P Patel.
来源: Circ Cardiovasc Interv. 2025年18卷8期e014915页
Acute decompensated aortic stenosis is an increasingly common condition associated with a high rate of morbidity, mortality, and health care resource utilization. Among patients with acute decompensated aortic stenosis, this study aimed to assess the impact of time to transcatheter aortic valve implantation (TAVI) on outcomes, hypothesizing that longer durations are associated with worse outcomes.
|